Haskel William M.

Avg. Two Year Performance

No purchase track record
(69%) Avg. Sale Return
(30%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return2%(4%)(20%)(78%)(69%)
Sale Success Rate1 of 160 of 160 of 160 of 160 of 16
Drugs » Biotechnology

CLO, General Counsel & Sec.:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Senior Vice President:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--